You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors

 

Online download statistics by month:

Online download statistics by month: April 2020 to September 2025

AbstractFullPdf
Apr 202032632688
May 202019519555
Jun 202012712775
Jul 2020616130
Aug 2020393917
Sep 2020646422
Oct 2020393914
Nov 2020464611
Dec 20201201202
Jan 2021636312
Feb 202154548
Mar 202111911912
Apr 202118418418
May 202111911918
Jun 2021404012
Jul 2021545417
Aug 202148487
Sep 2021404019
Oct 2021383833
Nov 2021363623
Dec 2021252514
Jan 2022363817
Feb 2022101116
Mar 2022282818
Apr 202240425
May 2022333312
Jun 2022353511
Jul 2022232511
Aug 2022363610
Sep 2022313115
Oct 2022333415
Nov 2022252716
Dec 202236376
Jan 202327275
Feb 202343435
Mar 202326277
Apr 2023232317
May 202311115
Jun 202320208
Jul 2023202012
Aug 202340406
Sep 202319197
Oct 202325257
Nov 202327275
Dec 2023333510
Jan 202417197
Feb 202428289
Mar 202437379
Apr 202425257
May 2024434314
Jun 202425269
Jul 2024404210
Aug 2024393611
Sep 2024282913
Oct 202435355
Nov 202449503
Dec 202438384
Jan 2025424410
Feb 20251331338
Mar 202539395
Apr 2025424215
May 2025343415
Jun 202530317
Jul 2025110
Sep 2025110
Total32433264914